Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Clusterin in Alzheimer's disease.

Wu ZC, Yu JT, Li Y, Tan L.

Adv Clin Chem. 2012;56:155-73. Review.

PMID:
22397031
2.

Clusterin: a forgotten player in Alzheimer's disease.

Nuutinen T, Suuronen T, Kauppinen A, Salminen A.

Brain Res Rev. 2009 Oct;61(2):89-104. doi: 10.1016/j.brainresrev.2009.05.007. Epub 2009 Aug 3. Review.

PMID:
19651157
3.

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.

Miners JS, Clarke P, Love S.

Brain Pathol. 2017 May;27(3):305-313. doi: 10.1111/bpa.12392. Epub 2016 Jul 8.

PMID:
27248362
4.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
5.

Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population.

Komatsu M, Shibata N, Kuerban B, Ohnuma T, Baba H, Arai H.

Psychogeriatrics. 2011 Mar;11(1):14-8. doi: 10.1111/j.1479-8301.2010.00346.x. Epub 2011 Feb 25.

6.

Apolipoprotein J (clusterin) and Alzheimer's disease.

Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J.

Microsc Res Tech. 2000 Aug 15;50(4):305-15. Review.

PMID:
10936885
8.

Relationship between multifunctional protein "clusterin" and Alzheimer disease.

Choi-Miura NH, Oda T.

Neurobiol Aging. 1996 Sep-Oct;17(5):717-22. Review.

PMID:
8892344
9.

Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.

Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z.

Neurosci Bull. 2014 Feb;30(1):162-8. doi: 10.1007/s12264-013-1391-2. Epub 2013 Dec 19. Review.

10.

[Apolipoprotein J and Alzheimer's amyloid beta solubility].

Matsubara E.

Nihon Ronen Igakkai Zasshi. 1999 Feb;36(2):110-5. Japanese. No abstract available.

11.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272
12.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology.

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56. Review.

PMID:
22917148
13.

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.

Lidström AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K.

Exp Neurol. 1998 Dec;154(2):511-21.

PMID:
9878186
14.

Mitochondrial dysfunction and Alzheimer's disease.

Maruszak A, Żekanowski C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16. Review.

PMID:
20624441
15.

Alzheimer's disease: the cholesterol connection.

Puglielli L, Tanzi RE, Kovacs DM.

Nat Neurosci. 2003 Apr;6(4):345-51. Review.

PMID:
12658281
16.

Clusterin and Alzheimer's disease.

Calero M, Rostagno A, Frangione B, Ghiso J.

Subcell Biochem. 2005;38:273-98. Review.

PMID:
15709484
17.

Clusterin mRNA and protein in Alzheimer's disease.

Baig S, Palmer LE, Owen MJ, Williams J, Kehoe PG, Love S.

J Alzheimers Dis. 2012;28(2):337-44. doi: 10.3233/JAD-2011-110473.

PMID:
22232000
18.

Cholesterol, lipids, amyloid Beta, and Alzheimer's.

Vestergaard M, Hamada T, Morita M, Takagi M.

Curr Alzheimer Res. 2010 May;7(3):262-70. Review.

PMID:
19715550
19.

Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease.

Xing YY, Yu JT, Cui WZ, Zhong XL, Wu ZC, Zhang Q, Tan L.

J Alzheimers Dis. 2012;29(3):515-9. doi: 10.3233/JAD-2011-111844.

PMID:
22258514

Supplemental Content

Support Center